close icon

NYSE Operator Can Fall 50% as Correction Begins

Exchanges don’t exist in a vacuum. There are companies whose entire operation is dedicated to running them. We recently wrote about CBOE Global Markets – the company operating, among others, the Chicago options exchange. Today, we would like to examine another major company in the field – Intercontinental Exchange Inc. – the company owning the NYSE.

Although the NYSE traces its roots back to 1792, the company that currently owns it was formed in 2000. Intercontinental Exchange Inc. became a public company in late-2005. Apart from the sharp declines in 2008-9 and 2020, the stock has been a very good performer. Currently around $115 a share, it is up 1374% since its IPO.

ICE, however, despite its strong fundamentals, is far from a fast-growth company. Its net profit has been hovering around $2B for the past three years now. Yet, the stock trades at a P/E higher than 30, which makes it quite expensive. That is not a problem until it is. No trend lasts forever and chasing the stock price as it keeps climbing will not work forever, either. Based on the Elliott Wave chart below, it can stop working sooner than some seem to think.

NYSE operator stock can tumble 50 percent in Elliott Wave correction

The weekly chart above shows that the stock of the NYSE ‘s parent company has drawn a complete impulse. The pattern is labeled I-through-V, where wave II marks the 2008-9 Financial Crisis and wave IV stands for last year’s coronavirus selloff.

What the bulls should worry about, besides the expensive valuation, is that a three-wave correction follows every impulse. Furthermore, the negative phase of the Elliott Wave cycle usually erases the entire fifth wave. So, if this count is correct, we can expect a decline back to the support of wave IV near $60 a share. Given that ICE just exceeded $121 in April, this could be a ~50% plunge.

Similar Elliott Wave setups occur in the Forex, crypto and commodity markets, as well. Our Elliott Wave Video Course can teach you how to uncover them yourself!



Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

Three Months Ahead of NovoCure ‘s 35% Plunge

Our first and only article on NovoCure stock was published almost three months ago, on July 1st. In it we shared our view that the tumor treatment company was not only significantly overvalued, but in immediate danger of a large stock price drop. The stock had just fell 15% in one day, despite positive TTFields…

Read More »

MongoDB – Bearish Pattern Joins Nosebleed Valuation

MongoDB Inc. is a general purpose database platform developer and provider. The company was founded in 2007, but only came public ten years later – in 2017. During the following four years, the stock has risen from an IPO price of $33 to $515 a share as of last week. So, it is fair to…

Read More »

Pandora Does Things Right. Stock May Need a Breather

When we wrote our previous article on Danish jewelry maker Pandora in December, 2020, the stock was up over three-fold since March. That recovery from DKK 180 to DKK 651 didn’t not come out of the blue, though. It was the result of a bullish setup we managed to identify as early as July 2019.…

Read More »

Match ‘s SP500 Inclusion a Good Excuse to Reach $200

Match Group Inc. rose over 10% in post-market trading Friday following reports that it is going to be included in the S&P 500. The company, which owns Tinder, OkCupid and most other major dating apps in the U.S., has a market cap of over $41B. Despite the anticipated “summer of love”, though, this is not…

Read More »

Cameco Stock Seems to Have Finally Turned a Corner

Uranium spot prices are on the verge of breaking above $34/lb, up over 80% from the bottom of $18/lb reached in late-2016. Cameco, as one of the world’s top uranium producers, is now seeing its stock price rising in tandem. Yesterday, it closed at $19.16 after reaching $21.95 in June. We first covered Cameco in…

Read More »

A Fresh Look At Cigna ‘s Elliott Wave Super Cycle

In a case study article on Cigna, published in October, 2016, we examined how a fundamentally sound and undervalued stock can still drop nearly 90%. The reason for that crash didn’t lie in some company specific issue. Rather it happened to occur during the biggest financial crisis in 80 years. Nevertheless, we made the point…

Read More »

CBOE Takeover Rumor Lifts Stock to Elliott Wave Target

We first wrote about CBOE Global Markets less than eight months ago. The S&P 500 had already recouped all its COVID selloff losses and was hovering at new all-time highs. CBOE, in contrast, was still down 30% from its 2018 record, trading below $97 a share. For some reason, the market was ignoring the company’s…

Read More »

More analyses